[1] The mechanism of action centres on mimicking the naturally occurring hormone GLP-1, which is released from the intestine in response to food intake
Li X, Jin Q, Yao Q, Xu B, Li L, Zhang S, Tu C (2018) The flavonoid quercetin ameliorates liver inflammation and fibrosis by regulating hepatic macrophages activation and polarization in Mice
95%CI = 0.270.76), valproate plus magnesium (ROM = 0.65
Tirzepatide dual-agonist mechanism offers advantages for body composition that single-agonist semaglutide may not match
Healthcare professionals should assess the need to commence pharmacotherapy (or continue pharmacotherapy if commenced prior to surgery), monitor for side effects, and titrate the dose accordingly
The cessation of GLP-1 therapy involves a "washout" period where the body re-adjusts to its baseline metabolic state